RECRUITING

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Rates of suicide have increased significantly over the past two decades, particularly among youth. Compared to the general population, autistic people are significantly more likely to think about suicide, attempt suicide, and die by suicide. Autistic individuals have identified suicide prevention as a top research priority; however, little is known about how to best help autistic youth at risk for suicide. The purpose of this study is to compare the effectiveness, feasibility, and acceptability of two suicide prevention strategies tailored for autistic individuals: the Safety Planning Intervention tailored for Autistic individuals (SPI-A) and SPI-A plus structured follow-up contacts (SPI-A+).

Official Title

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

Quick Facts

Study Start:2022-08-23
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05398250

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 12-24 years old
  2. * Able and willing to provide informed consent (age ≥18) or assent and parental consent (age \<18)
  3. * Able to speak English
  4. * Have received a safety plan tailored for autistic youth during a clinical visit
  1. * Altered mental status that precludes ability to provide informed assent or consent (acute psychosis, intoxication, or mania)

Contacts and Locations

Study Contact

Danielle Roubinov, PhD
CONTACT
919-843-5898
danielle_roubinov@med.unc.edu

Principal Investigator

Danielle Roubinov, PhD
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Shari Jager-Hyman, PhD
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

Kennedy Krieger Institute
Baltimore, Maryland, 21113
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27510
United States
Nationwide Children's Hospital
Columbus, Ohio, 43205
United States
Children's Hospital of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: University of North Carolina, Chapel Hill

  • Danielle Roubinov, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill
  • Shari Jager-Hyman, PhD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-23
Study Completion Date2026-09

Study Record Updates

Study Start Date2022-08-23
Study Completion Date2026-09

Terms related to this study

Keywords Provided by Researchers

  • Suicide Prevention
  • Autism Spectrum Disorder
  • Safety Planning Intervention

Additional Relevant MeSH Terms

  • Suicidal Ideation
  • Suicidal and Self-injurious Behavior
  • Suicide
  • Autism Spectrum Disorder